Download
Kinase Protein
Profiling Services
- Kinase Profiling Book ATP conc. = Km app, 1mM (
January 1, 2013
)
- Service Application Form ATP conc. = Km app, 1mM (
January 1, 2013
)
- Outline of Profiling Service ATP conc. = Km bin. (
January 1, 2013
)
- Outline of Profiling Service ATP conc. = 1mM (
January 1, 2013
)
Assay Development
Crystallography
Poster Presentation
-
Poster Presentation (2013 AACR Annual Meeting)
Title: Pathway oriented phospho-proteomics analysis with reverse phase protein array
(RPPA) technology in cell growth and cancer therapy
-
Poster Presentation (2013 AACR Annual Meeting)
Title: Highly sensitive kinase assays combining Carna Biosciences QSS Assist ELISA reagents with the Meso Scale Discovery MULTI-ARRAY platform
-
Poster Presentation (2011)
Title: A novel binding assay to identify inhibitors that bind to inactive forms of Bruton’s tyrosine kinase based on fluorescence resonance energy transfer
-
Poster Presentation (2011)
Title: The design and synthesis of a novel fluorogenic probe targeting inactive forms of Bruton's tyrosine kinase for high throughput binding assay
-
Poster Presentation (SBS, 2011)
Title: Site Specific Biotinylated Protein Kinase is Easy-to-Use Solution in the SPR Technology for Kinase Inhibitor Evaluation
-
Poster Presentation (Drug Discovery TARGET & TOOL, 2011)
Title: Site Specific Biotinylated Protein Kinase is Easy-to-Use Solution in the SPR Technology for Kinase Inhibitor Evaluation
-
Poster Presentation (Next-Gen Kinase Inhibitors, 2010)
Title: Activity and Affinity- based assay of FMS tyrosine kinase: the impact of kinase phosphorylation state on the activities of various kinase inhibitory compounds
-
Poster Presentation (SBS, 2010)
Title: Activity-based kinase selectivity profiling of clinically relevant tyrosine kinase inhibitors using QuickScout™
-
Poster Presentation (SBS, 2007)
Title: Comprehensive Protein Kinase Profiling Panel for Selective Inhibitor Screening provided by Carna Biosciences ”The Kinase company”
-
Poster Presentation (DDT, 2005)
Title: Entire human tyrosine kinase profiling panel will help to develop the specific kinase inhibitor
